Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Third Quarter 2020 Financial Results

Company Secures Three-Year Renewal of License and Supply Agreement with Lannett, A Generics Pharmaceutical Company, for Manufacturing of Verelan PM®, Verelan SR® and Verapamil PM Strong Technical...
November 02, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020

MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation,...
September 18, 2020 07:30 ET | Source: Recro Pharma, Inc.

Recro to Present at Oppenheimer Fall Healthcare Life Sciences & Medtech Summit

GAINESVILLE, Ga., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for the development,...
August 10, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Second Quarter 2020 Financial Results

Launches Clinical Trial Materials Business and Secures New Customers Company to Host Conference Call Today at 8:00 a.m. ET MALVERN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a...
August 06, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020

MALVERN, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for development,...
June 11, 2020 10:00 ET | Source: Recro Pharma, Inc.

Recro Highlights Manufacturing Readiness For Essential Drugs and Medical Supplies

Company Owns and Operates Over 120,000 Square Feet of U.S. cGMP and DEA-Licensed Contract Development and Manufacturing Facilities Focused on Creating Oral, Solid Dose Drug Products Long, Proven...
May 11, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports First Quarter 2020 Financial Results and Provides Update on COVID-19 Response and Impact

Company Generates $21.8 Million in First Quarter 2020 Revenues Revises Annual Revenue Guidance for 2020 MALVERN, Pa., May 11, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading...
May 08, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 11, 2020

MALVERN, Pa., May 08, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH) a leading contract development and manufacturing organization (CDMO), with integrated solutions for the development,...
May 01, 2020 16:05 ET | Source: Recro Pharma, Inc.

Recro Announces Change in Location of its 2020 Annual Meeting of Shareholders to its Corporate Headquarters

MALVERN, Pa., May 01, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH) (the “Company”), a high-performing, revenue generating contract development and manufacturing organization, today...
March 04, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Financial Results for the Year Ended 2019

Recro Completes Separation of Baudax Bio and Is Now a Pure Play CDMO Business Company Sets Annual Revenue Record; 2019 Revenues of $99.2 Million Company to Host Conference Call Today at 8:00 AM ET ...